Matrix attachment regions as targets for retroviral integration

Virology Journal

Volumn 2, Issue , 2005, Pages

  Johnson, Chassidy N ^a   Levy, Laura S ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1; MATRIX ATTACHMENT REGION; MOLONEY LEUKEMIA ONCOVIRUS; MURINE LEUKEMIA VIRUS; NONHUMAN; ONCOGENE; RETROVIRUS; ANIMAL; CELL LINE; COMPARATIVE STUDY; GENETICS; HUMAN; MOUSE; PHYSIOLOGY; VIRUS DNA CELL DNA INTERACTION;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1;

ANIMALS; CELL LINE; GAMMARETROVIRUS; HIV-1; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MATRIX ATTACHMENT REGIONS; MICE; VIRUS INTEGRATION;

EID: 24144499181     PISSN: 1743422X     EISSN: None     Source Type: Journal    
DOI: 10.1186/1743-422X-2-68     Document Type: Article

References (51)

1. Neil JC, Cameron ER: Retroviral insertion sites and cancer: fountain of all knowledge? Cancer Cell 2002, 2(4):253-255.
2. Weidhaas JB, Angelichio EL, Fenner S, Coffin JM: Relationship between retroviral DNA integration and gene expression. J Virol 2000, 74(18):8382-8389.
3. Robinson HL, Gagnon GC: Patterns of proviral insertion and deletion in avian leukosis virus-induced lymphomas. J Virol 1986, 57(1):28-36.
4. Rohdewohld H, Weiher H, Reik W, Jaenisch R, Breindl M: Retrovirus integration and chromatin structure: Moloney murine leukemia proviral integration sites map near DNase I-hypersensitive sites. J Virol 1987, 61(2):336-343.
5. Vijaya S, Steffen DL, Robinson HL: Acceptor sites for retroviral integrations map near DNase I-hypersensitive sites in chromatin. J Virol 1986, 60(2):683-692.
6. Goodenow MM, Hayward WS: 5′ long terminal repeats of mycassociated proviruses appear structurally intact but are functionally impaired in tumors induced by avian leukosis viruses. J Virol 1987, 61(8):2489-2498.
7. Panet A, Cedar H: Selective degradation of integrated murine leukemia proviral DNA by deoxyribonucleases. Cell 1977, 11(4):933-940.
8. Leclercq I, Mortreux F, Gabet AS, Jonsson CB, Wattel E: Basis of HTLV type 1 target site selection. AIDS Res Hum Retroviruses 2000, 16(16):1653-1659.
9. Scherdin U, Rhodes K, Breindl M: Transcriptionally active genome regions are preferred targets for retrovirus integration. J Virol 1990, 64(2):907-912.
10. Mooslehner K, Karls U, Harbers K: Retroviral integration sites in transgenic Mov mice frequently map in the vicinity of transcribed DNA regions. J Virol 1990, 64(6):3056-3058.
11. Narezkina A, Taganov KD, Litwin S, Stoyanova R, Hayashi J, Seeger C, Skalka AM, Katz RA: Genome-wide analyses of avian sarcoma virus integration sites. J Virol 2004, 78(21):11656-11663.
12. Ozawa T, Itoyama T, Sadamori N, Yamada Y, Hata T, Tomonaga M, Isobe M: Rapid isolation of viral integration site reveals frequent integration of HTLV-1 into expressed loci. J Hum Genet 2004, 49(3):154-165.
13. Stevens SW, Griffith JD: Human immunodeficiency virus type 1 may preferentially integrate into chromatin occupied by L1Hs repetitive elements. Proc Natl Acad Sci U S A 1994, 91(12):5557-5561.
14. Pruss D, Reeves R, Bushman FD, Wolffe AP: The influence of DNA and nucleosome structure on integration events directed by HIV integrase. J Biol Chem 1994, 269(40):25031-25041.
15. Pruss D, Bushman FD, Wolffe AP: Human immunodeficiency virus integrase directs integration to sites of severe DNA distortion within the nucleosome core. Proc Natl Acad Sci U S A 1994, 91(13):5913-5917.
16. Pryciak PM, Varmus HE: Nucleosomes, DNA-binding proteins, and DNA sequence modulate retroviral integration target site selection. Cell 1992, 69(5):769-780.
17. Pryciak PM, Sil A, Varmus HE: Retroviral integration into minichromosomes in vitro. Embo J 1992, 11(1):291-303.
18. Muller HP, Varmus HE: DNA bending creates favored sites for retroviral integration: an explanation for preferred insertion sites in nucleosomes. Embo J 1994, 13(19):4704-4714.
19. Wu X, Li Y, Crise B, Burgess SM: Transcription start regions in the human genome are favored targets for MLV integration. Science 2003, 300(5626):1749-1751.
20. Schroder AR, Shinn P, Chen H, Berry C, Ecker JR, Bushman F: HIV-1 integration in the human genome favors active genes and local hotspots. Cell 2002, 110(4):521-529.
21. Cereseto A, Giacca M: Integration site selection by retroviruses. AIDS Rev 2004, 6(1):13-21.
22. Wu X, Li Y, Crise B, Burgess SM, Munroe DJ: Weak palindromic consensus sequences are a common feature found at the integration target sites of many retroviruses. J Virol 2005, 79(8):5211-5214.
23. Wu X, Burgess SM: Integration target site selection for retroviruses and transposable elements. Cell Mol Life Sci 2004, 61(19-20):2588-2596.
24. Holman AG, Coffin JM: Symmetrical base preferences surrounding HIV-1, avian sarcoma/leukosis virus, and murine leukemia virus integration sites. Proc Natl Acad Sci U S A 2005, 102(17):6103-6107.
25. Holth LT, Chadee DN, Spencer VA, Samuel SK, Safneck JR, Davie JR: Chromatin, nuclear matrix and the cytoskeleton: role of cell structure in neoplastic transformation (review). Int J Oncol 1998, 13(4):827-837.
26. Bode J, Kohwi Y, Dickinson L, Joh T, Klehr D, Mielke C, Kohwi-Shigematsu T: Biological significance of unwinding capability of nuclear matrix-associating DNAs. Science 1992, 255(5041):195-197.
27. Cockerill PN, Garrard WT: Chromosomal loop anchorage sites appear to be evolutionarily conserved. FEBS Lett 1986, 204(1):5-7.
28. Yanagisawa J, Ando J, Nakayama J, Kohwi Y, Kohwi-Shigematsu T: A matrix attachment region (MAR)-binding activity due to a p114 kilodalton protein is found only in human breast carcinomas and not in normal and benign breast disease tissues. Cancer Res 1996, 56(3):457-462.
29. Leman ES, Getzenberg RH: Nuclear matrix proteins as biomarkers in prostate cancer. J Cell Biochem 2002, 86(2):213-223.
30. Coffey DS: Nuclear matrix proteins as proteomic markers of preneoplastic and cancer lesions : commentary re: G. Brunagel et al., nuclear matrix protein alterations associated with colon cancer metastasis to the liver. Clin. Cancer Res., 8: 3039-3045, 2002. Clin Cancer Res 2002, 8(10):3031-3033.
31. Kurre P, Morris J, Thomasson B, Kohn DB, Kiem HP: Scaffold attachment region-containing retrovirus vectors improve long-term proviral expression after transplantation of GFPmodified CD34+ baboon repopulating cells. Blood 2003, 102(9):3117-3119.
32. Agarwal M, Austin TW, Morel F, Chen J, Bohnlein E, Plavec I: Scaffold attachment region-mediated enhancement of retroviral vector expression in primary T cells. J Virol 1998, 72(5):3720-3728.
33. Lutzko C, Senadheera D, Skelton D, Petersen D, Kohn DB: Lentivirus vectors incorporating the immunoglobulin heavy chain enhancer and matrix attachment regions provide positionindependent expression in B lymphocytes. J Virol 2003, 77(13):7341-7351.
34. Shera KA, Shera CA, McDougall JK: Small tumor virus genomes are integrated near nuclear matrix attachment regions in transformed cells. J Virol 2001, 75(24):12339-12346.
35. Kulkarni A, Pavithra L, Rampalli S, Mogare D, Babu K, Shiekh G, Ghosh S, Chattopadhyay S: HIV-1 integration sites are flanked by potential MARs that alone can act as promoters. Biochem Biophys Res Commun 2004, 322(2):672-677.
36. Hansen GM, Skapura D, Justice MJ: Genetic profile of insertion mutations in mouse leukemias and lymphomas. Genome Res 2000, 10(2):237-243.
37. Li J, Shen H, Himmel KL, Dupuy AJ, Largaespada DA, Nakamura T, Shaughnessy JDJ, Jenkins NA, Copeland NG: Leukaemia disease genes: large-scale cloning and pathway predictions. Nat Genet 1999, 23(3):348-353.
38. Mikkers H, Allen J, Knipscheer P, Romeijn L, Hart A, Vink E, Berns A, Romeyn L: High-throughput retroviral tagging to identify components of specific signaling pathways in cancer. Nat Genet 2002, 32(1):153-159.
39. Starkey CR, Lobelle-Rich PA, Granger S, Brightman BK, Fan H, Levy LS: Tumorigenic potential of a recombinant retrovirus containing sequences from Moloney murine leukemia virus and feline leukemia virus. J Virol 1998, 72(2):1078-1084.
40. Johnson C, Lobelle-Rich PA, Puetter A, Levy LS: Substitution of feline leukemia virus long terminal repeat sequences into murine leukemia virus alters the pattern of insertional activation and identifies new common insertion sites. J Virol 2005, 79(1):57-66.
41. Glazko GV, Rogozin IB, Glazkov MV: Comparative study and prediction of DNA fragments associated with various elements of the nuclear matrix. Biochim Biophys Acta 2001, 1517(3):351-364.
42. Rogozin IB, Glazko GV, Glazkov MV: Computer prediction of sites associated with various elements of the nuclear matrix. Brief Bioinform 2000, 1(1):33-44.
43. Benham C, Kohwi-Shigematsu T, Bode J: Stress-induced duplex DNA destabilization in scaffold/matrix attachment regions. J Mol Biol 1997, 274(2):181-196.
44. Albrecht P, Bode J, Buiting K, Prashanth AK, Lohmann DR: Recurrent deletion of a region containing exon 24 of the RB1 gene caused by non-homologous recombination between a LINE-1HS and MER21B element. J Med Genet 2004, 41(12):e122.
45. Goetze S, Gluch A, Benham C, Bode J: Computational and in vitro analysis of destabilized DNA regions in the interferon gene cluster: potential of predicting functional gene domains. Biochemistry 2003, 42(1):154-166.
46. Goetze S, Baer A, Winkelmann S, Nehlsen K, Seibler J, Maass K, Bode J: Performance of genomic bordering elements at predefined genomic loci. Mol Cell Biol 2005, 25(6):2260-2272.
47. Kim R, Trubetskoy A, Suzuki T, Jenkins NA, Copeland NG, Lenz J: Genome-based identification of cancer genes by proviral tagging in mouse retrovirus-induced T-cell lymphomas. J Virol 2003, 77(3):2056-2062.
48. Klehr D, Maass K, Bode J: Scaffold-attached regions from the human interferon beta domain can be used to enhance the stable expression of genes under the control of various promoters. Biochemistry 1991, 30(5):1264-1270.
49. Goetze S, Huesemann Y, Baer A, Bode J: Functional characterization of transgene integration patterns by halo fluorescence in situ hybridization: electroporation versus retroviral infection. Biochemistry 2003, 42(23):7035-7043.
50. Liu J, Bramblett D, Zhu Q, Lozano M, Kobayashi R, Ross SR, Dudley JP: The matrix attachment region-binding protein SATB1 participates in negative regulation of tissue-specific gene expression. Mol Cell Biol 1997, 17(9):5275-5287.
51. Zink D, Fischer AH, Nickerson JA: Nuclear structure in cancer cells. Nat Rev Cancer 2004, 4(9):677-687.